Filippo Milano

Trials

Studies that name Filippo Milano as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:11 UTC. Open this list on ClinicalTrials.gov

• Ph2
  NCT07046078 · Combination Chemotherapy (FLAG-Ida) Followed Immediately by Reduced-Intensity Total Body Radiation Therapy and Donor Hematopoietic Cell Transplant for the Treatment of Adults Age 60 and Older With Newly Diagnosed Adverse-Risk Acute Myeloid Leukemia or Other High-Grade Myeloid Cancer

  Fred Hutchinson Cancer Center · recruiting · Acute Leukemia of Ambiguous Lineage, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia · principal investigator
• Ph2
  NCT04526288 · CPX-351 Versus Immediate Stem Cell Transplantation for the Treatment of High-Grade Myeloid Cancers With Measurable Residual Disease

  Fred Hutchinson Cancer Center · terminated · Acute Myeloid Leukemia, Myelodysplastic Syndrome With Excess Blasts-2, Myeloid Neoplasm · principal investigator
• Ph1
  NCT04375631 · CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia

  Fred Hutchinson Cancer Center · recruiting · Recurrent Acute Myeloid Leukemia, Recurrent Chronic Myelomonocytic Leukemia, Recurrent Myelodysplastic Syndrome · principal investigator
• Ph2
  NCT04083170 · Cord Blood Transplant With Dilanubicel for the Treatment of HIV Positive Hematologic Cancers

  Fred Hutchinson Cancer Center · terminated · Acute Erythroid Leukemia, Acute Lymphoblastic Leukemia, Acute Megakaryoblastic Leukemia · principal investigator
• Ph2
  NCT03399773 · Infusion of Expanded Cord Blood Cells in Addition to Single Cord Blood Transplant in Treating Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplastic Syndromes

  Fred Hutchinson Cancer Center · active not recruiting · Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive · principal investigator
• Ph2
  NCT01690520 · Donor Umbilical Cord Blood Transplant With or Without Ex-vivo Expanded Cord Blood Progenitor Cells in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, or Myelodysplastic Syndromes

  Nohla Therapeutics, Inc. · completed · Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission · principal investigator
• Ph2
  NCT00796068 · Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematological Cancer Who Are Undergoing Umbilical Cord Blood Transplant

  Fred Hutchinson Cancer Center · completed · Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 12:11 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

• CCR5 Analyses in HIV Infected Hematology Patients undergoing Umbilical Cord Blood Allogeneic Transplantation
  R34HL142322 · NHLBI · FRED HUTCHINSON CANCER CENTER · fiscal years 2018 to 2020 · $245,239 awarded in 2020
  Grant number is on one of their registry trials

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• Cancer Center Administration
  P30CA015704 · NCI · FRED HUTCHINSON CANCER CENTER · PI WENDY LAW · fiscal years 2018 to 2026
  Named on NCT04375631, NCT03399773, NCT01690520
• P50HL110787
  RePORTER returned no project for this number; it is shown as the registry gives it.
  Named on NCT03399773, NCT01690520